Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05647746
Other study ID # AJ259
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 10, 2022
Est. completion date May 31, 2023

Study information

Verified date February 2024
Source Compumedics Limited
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To study whether Somfit is substantially equivalent to the existing approved devices for full polysomnography and home sleep apnea testing


Description:

Sleep is recognized as one of the three pillars of health (i.e. nutrition, exercise and sleep). Poor quality and fragmented sleep leads to an increase in the risk for development of chronic health conditions. Given the importance of good quality sleep and its critical role in overall well-being, there is a need for regular monitoring and assessment of sleep quality in individuals. However, current technologies will only allow for this to be performed in sleep clinics and with the help of full polysomnography (PSG) systems which require the patients to spend a night at the clinic with several wired electrodes connected to their scalp. This "gold standard" technology is expensive and therefore does not allow to meet public health demand for diagnosis of sleep disorders, especially obstructive sleep apnea (OSA) and also can be uncomfortable for the patients and distort their natural sleep architecture. To solve this problem, Compumedics has recently developed a miniaturized, portable, automated and affordable sleep monitoring system with code name of "Somfit" which is attached to patients' forehead and can be used in the comfort of patients' home. While Somfit has already gained TGA approval, the aim of this study is to compare Somfit with the "gold standard" PSG and another approved portable sleep testing device, Itamar WatchPAT One, in terms of accuracy of characterising sleep neurological architecture and diagnosing OSA, with the objective of applying for the international regulatory approvals.


Recruitment information / eligibility

Status Completed
Enrollment 108
Est. completion date May 31, 2023
Est. primary completion date February 28, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Individuals aged 18 years or over - Be able to give informed consent - Referral for a diagnostic sleep study with indication of suspected sleep disordered breathing or history of diagnosed sleep disordered breathing Exclusion Criteria: - Less than 18 years of age - Unable or not willing to provide informed consent - Need for nursing attendance during the time between 9 pm and 9 am - Use of any OSA treatments during any part of the PSG study - Previous reaction to skin preparation, tapes and electrode gels used at PSG

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Compumedics Somfit HSAT device, WatchPAT HSAT device, Compumedics Grael /E-series PSG system
Each intervention is a separate diagnostic device. They will all be operating at the same time

Locations

Country Name City State
Australia SleepMetrics Pty Ltd Heidelberg VUC

Sponsors (1)

Lead Sponsor Collaborator
Compumedics Limited

Country where clinical trial is conducted

Australia, 

Outcome

Type Measure Description Time frame Safety issue
Other Respiratory Event Index (REI) for Somfit Additional outcome for sleep quality The measure will be calculated for every participant following a single night sleep recording
Other Oxygen Desaturation Index (ODI) for Somfit Additional outcome for sleep quality The measure will be calculated for every participant following a single night sleep recording
Other Average pulse rate (PR) for Somfit Additional outcome for sleep quality The measure will be calculated for every participant following a single night sleep recording
Primary The AHI difference between the test device (Somfit) and gold standard (PSG) AHI is the apnea hypopnea index, main measure of presence/severity of OSA (obstructive sleep apnea). it will test the null hypothesis that Somfit AHI is not equivalent to the AHI reported by PSG Data required for the primary outcome measure are generated in the course of single night sleep recording for every participant. Statistical estimation will be performed after completion of all sleep recordings
Primary The AHI difference between the test device (Somfit) and predicate device (WatchPAT) AHI is the apnea hypopnea index, main measure of presence/severity of OSA (obstructive sleep apnea). it will test the null hypothesis that Somfit AHI is not equivalent to the AHI reported by PSG Data required for this primary outcome measure are generated in the course of single night sleep recording for every participant. Statistical estimation will be performed after completion of all sleep recordings
Secondary Difference between hypnogram percent agreements between WatchPAT and PSG, and between Somfit and PSG It will test the null hypothesis that the accuracy of sleep staging performed by the test device (Somfit) is inferior to that of the predicate device (WatchPAT) Data required for this outcome measure are generated in the course of single night sleep recording for every participant. Statistical estimation will be performed after completion of all sleep recordings
Secondary Hypnogram percent agreement between Somfit and PSG It will test the null hypothesis that the accuracy of sleep staging performed by the test device (Somfit) is inferior to that demonstrated by the accredited sleep technologists Data required for this outcome measure are generated in the course of single night sleep recording for every participant. Statistical estimation will be performed after completion of all sleep recordings
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05547477 - Continuous EMG Measurements in Children With Asthma During Sleep
Completed NCT01503164 - Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism N/A
Recruiting NCT00863421 - Sleep Disordered Breathing in Patients With Chronic Heart Failure N/A
Completed NCT00841906 - Alice PDx User/Validation Extended Trial N/A
Not yet recruiting NCT05462834 - Impact of Nocturnal Hypoxemia on Glucose in High Altitude Sleep Disordered Breathing N/A
Recruiting NCT01785199 - Effects of Head Elevation by a Bed on Sleep-disordered Breathing Phase 1
Recruiting NCT06043830 - Managing Opioid Related Sleep Apnea With Acetazolamide Phase 2
Recruiting NCT04351698 - SMILES: Study of Montelukast in Sickle Cell Disease Phase 2/Phase 3
Active, not recruiting NCT05643352 - Barbed Reposition Pharyngoplasty in Patients Complaining of Unilevel Palatal Snoring N/A
Recruiting NCT03142022 - Sleep-disordered Breathing After Solid Organ Transplantation
Recruiting NCT05336890 - Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
Recruiting NCT05466864 - Screening of OSA in Hospitalized Stroke Patients Using BSP N/A
Recruiting NCT05661747 - Dental Appliance to Treat SDB in Children Phase 4
Completed NCT02855515 - Drug-Induced Sleep Endoscopy for the Optimisation of Treatment of Patients With Obstruction Sleep Apnoea N/A
Recruiting NCT05575401 - Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy N/A
Completed NCT02923505 - Effect of Positive Airway Pressure Therapy on Hospitalization and Mortality in SDB Patients With Comorbid Chronic Obstructive Pulmonary Disease (COPD) or/and Heart Failure (HF)
Completed NCT06154577 - Tongue Morphology and Posterior Airway Space as Predictors of Response in Patientswith Hypoglossal Nerve Stimulation Therapy
Recruiting NCT04331821 - READ-ASV Registry - Phase II
Completed NCT02830074 - Treatment of Sleep-disordered Breathing in Patients With SCI N/A
Completed NCT02245659 - Effect of CPAP Treatment on Glycemic Control in Gestational Diabetes: A Pilot Randomized-Controlled Trial N/A